Potent and selective dual mTORC1 and 2 inhibitor (IC50
= 1.5 nM). Exhibits >300-fold selectivity for mTOR over PI 3-kinase isoforms. Orally bioavailable.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Discovery of AZD3147: a potent, selective dual inhibitor of mTORC1 and mTORC2.
Pike et al.